WallStSmart
PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$3.40
+12.96% today

Updated 2026-10-28

Market cap
$15.89M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-12.56
Dividend yield
—
52W range
$2 – $21
Volume
0.1M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
10.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Altman Z 10.54 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-8.64M

Key financials

Revenue Net Income Free Cash Flow
Metric2023202420252026TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$8.01M$-51.16M$1.01M$-6.94M$-6.94M
EPS————$-12.56
Free cash flow$-2153.00$-2.95M$-3.74M$-8.64M$-8.64M
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PBM$15.89M264.33.05.07.3—Avoid
LLY$1.12T769.310.05.06.0—Strong Buy
JNJ$615.87B574.78.52.75.5-83.05%Buy
ABBV$504.37B736.78.54.05.0-86.73%Strong Buy
UNH$360.32B626.76.04.75.5-25.92%Buy
MRK$360.08B364.04.52.05.0-73.68%Hold

Smart narrative

Psyence Biomedical Ltd. Common Shares trades at $3.40. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 10.54, it sits in the safe zone.

Frequently asked questions

What is Psyence Biomedical Ltd. Common Shares's stock price?

Psyence Biomedical Ltd. Common Shares (PBM) trades at $3.40.

Is Psyence Biomedical Ltd. Common Shares overvalued?

Psyence Biomedical Ltd. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Psyence Biomedical Ltd. Common Shares's Altman Z-Score is 10.54, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-74.30%
Beta1.69
50D MA$4.88
200D MA$4.89
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—